# US 2023/0389830 A1 · Continuous analyte measurement systems and systems and methods for implanting them

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0389830 A1
- Document ID: US20230389830A1
- Status: Published application
- Kind: A1
- Application number: 18/454,348
- Filed: 2023-08-23
- Published: 2023-12-07
- Earliest claimed: 2009-07-23
- Assignees: Abbott Diabetes Care Inc.
- Applicants: Abbott Diabetes Care Inc.
- Inventors: Udo Hoss; John Charles Mazza; Phu Le
- Web page: https://patentgrep.com/patent/US20230389830A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/1495: Calibrating or testing of in-vivo probes
- A61B 5/6833: {Adhesive patches}
- A61B 5/7221: {Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217)}
- A61B 5/002: {Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence)}
- A61B 2560/0443: Modular apparatus
- A61B 2562/227: Sensors with electrical connectors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.

## Claims

### Claim 1

A glucose monitoring system comprising:
a data processing unit configured to be mounted on a skin surface including:
one or more processors,
one or more memories coupled with the one or more processors,
a battery coupled to the one or more processors,
an RF transmitter/receiver coupled to the one or more processors, and
a fixation element comprising an adhesive configured to secure the data processing unit to the skin surface;
a glucose sensor configured to generate electrical signals indicative of levels of glucose in an interstitial fluid, the glucose sensor including:
a proximal portion electrically coupled to the one or more processors of the data processing unit, and
a distal portion configured to be inserted through the skin surface and in contact with the interstitial fluid, the distal portion including:
a plurality of electrodes including a working electrode and a second electrode, wherein the second electrode comprises a reference electrode, and
an enzyme comprising glucose oxidase disposed proximate the working electrode;
wherein the glucose sensor comprises a predictable in vivo sensitivity drift and the one or more memories have a drift profile stored thereon;
wherein the one or more memories store instructions which, when executed by the one or more processors determine a glucose level based on the electrical signals generated by the glucose sensor and the drift profile; and
wherein the glucose monitoring system does not require user-initiated calibration during a life of the glucose sensor extending between 3 and 14 days.

### Claim 2 (depends on 1)

The glucose monitoring system of claim 1, wherein the second electrode further comprises a counter electrode.

### Claim 3 (depends on 1)

The glucose monitoring system of claim 1, wherein the distal portion of the glucose sensor further comprises a mass transport limiting layer configured to reduce a rate of mass transport of glucose into a region proximate the working electrode.

### Claim 4 (depends on 3)

The glucose monitoring system of claim 3, wherein the mass transport limiting layer comprises a zwitterionic moiety.

### Claim 5 (depends on 3)

The glucose monitoring system of claim 3, wherein the mass transport limiting layer comprises at least one of a poly(ethylene glycol) modifier, hydroxyl modifier, and polyhydroxyl modifier.

### Claim 6 (depends on 1)

The glucose monitoring system of claim 1, where the distal portion of the glucose sensor further comprises an interferent eliminating layer disposed between the working electrode and the glucose oxidase.

### Claim 7 (depends on 1)

The glucose monitoring system of claim 1, wherein the distal portion of the glucose sensor comprises a first width of 0.15 mm or less.

### Claim 8 (depends on 7)

The glucose monitoring system of claim 7, wherein the proximal portion of the glucose sensor comprises a second width, wherein the first width and the second width are substantially the same.

### Claim 9 (depends on 1)

The glucose monitoring system of claim 1, wherein the data processing unit further comprises a temperature detection section operatively coupled to the one or more processors.

### Claim 10 (depends on 9)

The glucose monitoring system of claim 9, wherein the instructions, when executed by the one or more processors, determine the glucose level based further on a temperature measurement determined by the temperature detection section.

### Claim 11 (depends on 1)

The glucose monitoring system of claim 1, where in the data processing unit further comprises a clock configured to supply real time information to the one or more processors.

### Claim 12 (depends on 1)

The glucose monitoring system of claim 1, wherein the glucose sensor detects hydrogen peroxide to generate the electrical signals indicative of levels of glucose.

### Claim 13 (depends on 1)

The glucose monitoring system of claim 1, further comprising a receiver unit including:
one or more receiver processors;
one or more receiver memories coupled with the one or more receiver processors;
a receiver RF receiver/transmitter coupled to the one or more receiver processors and configured to communicate with the RF receiver/transmitter of the data processing unit via a communication link; and
a battery coupled to the one or more receiver processors.

### Claim 14 (depends on 13)

The glucose monitoring system of claim 13, wherein the communication link uses a Bluetooth enabled communication protocol.

### Claim 15 (depends on 13)

The glucose monitoring system of claim 13, wherein the system is configured to provide an alarm when a glucose condition is detected based at least in part on the determined glucose level.

### Claim 16 (depends on 15)

The glucose monitoring system of claim 15, wherein the glucose condition comprises hypoglycemia.

### Claim 17 (depends on 15)

The glucose monitoring system of claim 15, wherein the glucose condition comprises hyperglycemia.

### Claim 18 (depends on 15)

The glucose monitoring system of claim 15, wherein the glucose condition comprises impending hypoglycemia.

### Claim 19 (depends on 15)

The glucose monitoring system of claim 15, wherein the glucose condition comprises impending hyperglycemia.

### Claim 20 (depends on 15)

The glucose monitoring system of claim 15, wherein the alarm comprises an auditory and visual alarm.

### Claim 21 (depends on 14)

The glucose monitoring system of claim 14, wherein the alarm comprises a vibratory and visual alarm.

### Claim 22 (depends on 1)

The glucose monitoring system of claim 1, further comprising an insertion device having an insertion needle having an opening configured to receive the distal portion of the glucose sensor.

### Claim 23 (depends on 22)

The glucose monitoring system of claim 22, wherein the opening comprises a longitudinal opening having a u-shaped cross-section.

### Claim 24 (depends on 22)

The glucose monitoring system of claim 22, wherein the opening comprises a longitudinal opening having a v-shaped cross section.

### Claim 25 (depends on 22)

The glucose monitoring system of claim 22, wherein the opening comprises a longitudinal opening having a c-shaped cross section.

### Claim 26 (depends on 22)

The glucose monitoring system of claim 22, wherein the insertion device further comprises a body having a distal base portion, the distal base portion including a bottom surface configured for placement on the skin surface.

### Claim 27 (depends on 26)

The glucose monitoring system of claim 26, where in the insertion device further comprises a plunger positioned within the body and movable perpendicular to the skin surface, the plunger coupled to the insertion needle.

### Claim 28 (depends on 27)

The glucose monitoring system of claim 27, wherein the insertion device further comprises a spring providing a bias on the plunger to retract the insertion needle after the sensor is inserted through the skin surface.

### Claim 29 (depends on 28)

The glucose monitoring system of claim 28, wherein the insertion device comprises a plastic.

### Claim 30 (depends on 29)

The glucose monitoring system of claim 29, wherein the insertion device is disposable.
